Ultra Low Doses of Rituximab in RA: Dr. Eric Dein and Nathan den Broeder Save Nov 08, 2021 4:29 pm In this interview, panelists discuss abstract #1443 presented at the ACR21 annual meeting. ADD THE FIRST COMMENT If you are a health practitioner, you may Login/Register to comment.Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.